Sort
35,931 grants matching “parkinsons”
Endotoxin Exposure and Risk of Parkinsonism
$524,704Harvey Checkoway · University Of California, San Diego · R01 · FY2014 · ES
Role of arginylation in prevention of alpha synuclein-driven neurodegeneration
$524,691Anna S Kashina · University Of Pennsylvania · R01 · FY2022 · NS
Role of arginylation in prevention of alpha synuclein-driven neurodegeneration
$524,691Anna S Kashina · University Of Pennsylvania · R01 · FY2023 · NS
Optimizing Patient-Specific Deep Brain Stimulation Models Using Electrophysiology
$524,645Svjetlana Miocinovic · Emory University · R01 · FY2022 · NS
Molecular Physiology of NMDA Receptors
$524,435Gabriela Popescu · State University Of New York At Buffalo · R35 · FY2023 · NS
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
$524,377Fay Bahling Horak · Oregon Health & Science University · R01 · FY2023 · HD
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
$524,377Fay Bahling Horak · Oregon Health & Science University · R01 · FY2022 · HD
Mobility in Daily Life and Falls in Parkinson's Disease: Potential for Rehabilitation
$524,377Fay Bahling Horak · Oregon Health & Science University · R01 · FY2021 · HD
Brain Prostheses: Promoting High Neuron Connectivity
$524,359William G Shain · Wadsworth Center · R01 · FY2006 · NS
Functions of Metabotropic Glutamate Receptor Subtypes
$524,289P Jeffrey Conn · Vanderbilt University · R37 · FY2018 · NS
Role of arginylation in prevention of alpha synuclein-driven neurodegeneration
$524,288Anna S Kashina · University Of Pennsylvania · R01 · FY2021 · NS
Genomic Screen To Identify Alzheimers Disease Genes
$524,265Duke University · R01 · FY2003 · NS
Role of meningeal lymphatic vasculature in neuroimmune communication development
$524,089Jean-Leon Thomas · Yale University · R01 · FY2023 · NS
TH and GTPCHI gene therapy for Parkinson's disease
$523,997Jeffrey H Kordower · Rush University Medical Center · R01 · FY2007 · NS
Prospective memory impairment in Parkinson disease-related cognitive decline: Intervention and mechanisms
$523,969Erin Foster · Washington University · R01 · FY2020 · AG
PARKINSON'S DISEASES SUSCEPTIBILITY GENES AND PESTICIDES
$523,834University Of California Los Angeles · R01 · FY2004 · ES
Saccade Target Selection Frontal Cortex
$523,728Jeffrey D Schall · Vanderbilt University · R01 · FY2015 · EY
Computational Strategies for Balancing Trade-offs between Risk and Effort during Walking
$523,720James Finley · University Of Southern California · · FY2021 · SBE
ROS driven mitochondrial-telomere dysfunction during environmental stress
$523,668Bennett Van Houten · University Of Pittsburgh At Pittsburgh · R33 · FY2019 · ES
Chaperone Protein and Protein Conformational Switches
$523,649Susan L. Lindquist · Whitehead Institute For Biomedical Res · R01 · FY2007 · GM
Effect Of Drugs of Abuse On Synaptic Transmission In Nucleus Accumbens
$523,616Carl Lupica · National Institute On Drug Abuse · ZIA · FY2020 · DA
Identifying causal genetic variants and molecular mechanisms impacting mental health
$523,574Stephen Montgomery · Stanford University · R01 · FY2025 · MH
Defining a Molecular Link between Parkinson and Gaucher Diseases
$523,375Jennifer Lee · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
ALZHEIMERS RESEARCH PROJECT: Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)
$523,375Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG
Neuroethics of aDBS Systems Targeting Neuropsychiatric and Movement Disorders
$523,368Gabriel Lazaro-Munoz · Baylor College Of Medicine · R01 · FY2019 · MH